Login
Register
EN
Loading...
HAS-BLED — online calculator | DOZATOR
Home
Tests
HAS-BLED
HAS-BLED
Subscribe
Assessment of major bleeding risk in patients taking anticoagulants to evaluate the risk-benefit ratio in the treatment of atrial fibrillation.
Back to tests
Select the factors from the listed that the patient has:
Arterial hypertension: systolic BP >160 mm Hg (+1)
Renal impairment: dialysis, transplanted kidney or serum creatinine level ≥200 μmol/l (+1)
Liver impairment: cirrhosis or bilirubin >2x normal with AST/ALT/ALP >3x normal (+1)
Stroke in medical history (+1)
Prior bleeding with hemoglobin decrease >2 g/l (+1)
Unstable INR: <60% of time in therapeutic range (+1)
Advanced age: >65 years (+1)
Medications: concurrent use of drugs that increase bleeding tendency: antiplatelet agents, NSAIDs (+1)
Alcohol: >8 servings per week (+1)